Most Popular News Today

• WidePoint Sets Second Quarter 2021 Conference Call for Monday, August 16, 2021 at 4:30 p.m. ET

  Aug 2 MicroCapNewsDaily

  August 2, 2021

  FAIRFAX, VA / ACCESSWIRE / August 2, 2021 / WidePoint Corporation (NYSE American:WYY), the leading provider of Trusted Mobility Management (TM2) specializing in Telecommunications Lifecycle more...

• Gevo Adds Jaime Guillen to Board of Directors

  Aug 2 MicroCapNewsDaily

  August 2, 2021

  ENGLEWOOD, Colo., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ: GEVO) announced today the appointment of Jaime Guillen to its Board of Directors. Mr. Guillen is a more...

• Entera Bio to Present Phase 2 EB613 Oral PTH Osteoporosis Treatment 3-Month Findings at the American Society for Bone and Mineral Research Annual Meeting

  Aug 2 MicroCapNewsDaily

  August 2, 2021

  ‒ The Study’s Primary Endpoint was Met; P1NP, a Biochemical Marker of Bone Formation, was Significantly Increased at Month 3 in EB613 2.5 mg Treatment Group Versus Placebo ‒ more...

• Evoke Pharma and EVERSANA Announce Support of The International Foundation for Gastrointestinal Disorders’ (IFFGD) August Gastroparesis Awareness Month

  Aug 2 MicroCapNewsDaily

  August 2, 2021

  Participating and Sponsorship in Upcoming Digestive Health Virtual Walk SOLANA BEACH, Calif., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Evoke Pharma ® (NASDAQ: EVOK), a specialty more...

• Climb Channel Solutions Unveils Its Brand New Cloud Marketplace – Expedition

  Aug 2 MicroCapNewsDaily

  August 2, 2021

  EATONTOWN, N.J., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Climb Channel Solutions, an international specialty technology distributor and wholly-owned subsidiary of Wayside Technology Group, Inc more...

• CymaBay Announces $100 Million Non-Dilutive Financing with Abingworth

  Aug 2 MicroCapNewsDaily

  August 2, 2021

  Risk-sharing agreement with Abingworth will fund seladelpar Phase 3 development program for PBC CymaBay retains full worldwide commercial rights to seladelpar more...

• Mustang Bio Receives European Medicines Agency PRIME Designation for MB-107 to Treat X-Linked Severe Combined Immunodeficiency in Newly Diagnosed Infants

  Aug 2 MicroCapNewsDaily

  August 2, 2021

  WORCESTER, Mass., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical break more...

• Aridis Pharmaceuticals Announces $25 Million Registered Direct Offering Priced at a Premium to Market

  Aug 2 MicroCapNewsDaily

  August 2, 2021

  Aridis Pharmaceuticals Announces $25 Million Registered Direct Offering Priced at a Premium to Market PR Newswire LOS GATOS, Calif. , more...